Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Karuna Therapeutics, Inc. (KRTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K8-K10-K8-K10-K10-K10-KS-1
Revenues   [+]10.6224.237.0128.20.00.00.00.0
            Revenue growth  -71.2%74.9%      
Cost of goods sold  0.0300.30.0180.80.00.00.00.0
Gross profit  10.6-76.137.0-52.60.00.00.00.0
            Gross margin  100.0%-33.9%100.0%-41.0%    
Selling, general and administrative   [+]300.376.1180.852.671.845.43.01.2
Research and development        11.53.6
Other operating expenses  -29.5137.5-0.138.6-6.6-2.9  
EBITDA   [+]-259.0 -143.2 -65.1-42.5-14.5-4.8
            EBITDA margin  -2435.3%-129.2%-387.5%-112.2%    
Depreciation and amortization  1.1 0.5 0.10.10.00.0
EBIT   [+]-260.2-289.7-143.7-143.9-65.2-42.5-14.5-4.8
            EBIT margin  -2445.8%-129.2%-388.9%-112.2%    
Interest income, net   [+]14.214.20.50.53.32.50.0-0.6
Other income (expense), net   [+]-28.90.6-0.6-0.4-6.6-4.0-3.0-0.7
Pre-tax income  -274.9-274.9-143.8-143.8-68.5-44.0-17.5-6.0
Income taxes  1.41.40.00.00.00.00.00.0
            Tax rate       0.0%0.0%0.0%
Net income  -276.3-276.3-143.8-143.8-68.6-44.0-17.5-6.0
            Net margin  -2597.9%-123.2%-389.0%-112.2%    
   
Basic EPS   [+]($8.74)($8.74)($4.94)($4.94)($2.59)($3.68)($4,378,000.00) 
Diluted EPS   [+]($8.74)($8.74)($4.94)($4.94)($2.59)($3.68)($4,378,000.00) 
   
Shares outstanding (basic)   [+]31.631.629.129.126.412.00.0 
Shares outstanding (diluted)   [+]31.631.629.129.126.412.00.0 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy